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Diagnosis of diseases, especially qualification for treatment
should be based on the methods properly optimized in
order to minimize the risk of incorrect qualification to
unnecessary treatments, or neglecting treatment wherever
it is needed. Among possible alternatives for routine
allergy diagnostic tests, hopeful mentions can be found of
the basophil activation test (BAT), which replicates in
vitro reactions that occur in the body during basophil
response to allergens, thus giving a chance for forecasting
the severity of allergic reaction.
Aim
The aim of the study was to optimize the basophil acti-
vation test in the detection of house dust mite allergy in
Polish children with allergic respiratory diseases.
Patients and methods
The study involved 32 patients, with symptoms of asthma
or allergic rhinitis, qualified for sIT with the D pteronyssi-
nus allergen by an experienced pediatric allergist. The con-
trol group consisted of an equal number of sex- and age-
matched children with the same clinical diagnoses, yet
sensitized to allergens other than D. pteronyssinus. In all
patients, the BAT test was performed with five dilutions of
D. pteronyssinus allergen. In order to detect possible
cross-reactivity, BAT was also carried out with one
dilution of D. farinae. The results were analyzed by the
means of ROC.
Results
The highest diagnostic efficiency in the analyzed
population was yielded by the cut-off of 9.76% of activated
basophils after activation with a single allergen concentra-
tion of 2.25 ng/ml (sensitivity 90,63%, specificity 100%).
The computed value differed significantly from the cut-off
value of 15% proposed by the manufacturer of the test.
Qualification of the patients with the use of the proposed
protocol and cut-off value did not differ from the “gold
standard”, i.e. qualification by the physician, while adop-
tion of the parameters proposed by the manufacturer
would result in a significant difference in this regard.
Conclusions
BAT is a useful method in the diagnosis and qualification
of children with asthma and allergic rhinitis for the aller-
gen-specific immunotherapy with house dust mite aller-
gens. Optimal cut-off values for the test differ from those
proposed by the manufacturer of the reagents. Facing the
risk of incorrect qualification of patients for costly, long-
lasting and potentially risky allergen-specific immunother-
apy, incurring the cost of basophil activation test seems
justified, especially in the case of diagnostic doubts.
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